Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)
Children's Oncology Group
EMD Serono
National Cancer Institute (NCI)
City of Hope Medical Center
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
Radiation Therapy Oncology Group
Dana-Farber Cancer Institute
Vanderbilt-Ingram Cancer Center